Student presenter: Dinindu Gunasekara, PhD Candidate (Supervisor: Dr. Lindsay Beaton)
Title: Monte Carlo Simulations of Space Radiation Exposure on Lymphocyte Cells for Biodosimetry Applications
Abstract:
Ionizing radiation presents one of the primary health risks of long-term spaceflight and must be accurately quantified to protect astronaut health. Biodosimetry techniques use an individual’s biological response to quantify the amount of radiation absorbed while taking into account biological factors and stressors. This is accomplished using a pre-flight calibration curve (CC) produced using an X-ray source. However, during extended stays on the International Space Station (ISS), astronauts are exposed to a broad range of particles with varying energies. The resulting complex mixed radiation field differs in composition from the X-ray reference exposure used for the CC. To improve this approximation, a computational model can be used to assess the impact of employing a more realistic source of radiation. Modelling of radiation transport and energy deposition was done in a lymphocyte cell using the Monte Carlo code Geant4-DNA. The output was used in the Mechanistic DNA Damage and Repair (MEDRAS) model. This mechanistic model calculates the misrepair of chromosome damage to identify the endpoints of interest. The space radiation environment incident on a phantom inside the ISS module was modelled and the resulting fluences were used to produce a space-equivalent CC. The fluence fractions of the five most abundant particles including gammas (71.85 %), neutrons (15.39 %), protons (10.35 %), electrons (2.69 %), and alphas (0.19 %). By comparing the simulated CCs, a conversion factor between the two curves can be determined and then be used to adjust future X-ray curves to better reflect the space radiation environment.
Member speaker: Dr. Glenn Wells, Medical Physicist, Department of Nuclear Cardiology, University of Ottawa Heart Institute
Title: Building Better Blood-flow Measurements with SPECT
Abstract:
Absolute measurements of myocardial blood flow (MBF) improve the diagnostic and prognostic accuracy of myocardial perfusion imaging with nuclear medicine. PET remains the clinical standard for measuring MBF but access is limited and developing SPECT MBF greatly increases the number of patients that can be reached. We introduced SPECT MBF into clinical practice several years ago, but have continued to work on improving the technique since. This talk will describe some the changes made to acquisition and processing that we have implemented after its clinical introduction and are currently developing.